Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|October 2, 2015
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In SituMathias Worni, Igor Akushevich, Rachel Greenup, et al.
BMC Medicine|November 11, 2009
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysisShalini L Kulasingam, Raghu Rajan, Yvan St Pierre, et al.
American Journal of Obstetrics and Gynecology|February 27, 2013
Perinatal implications of motor vehicle accident trauma during pregnancy: identifying populations at riskTomas Luley, C Brennan Fitzpatrick, Chad A Grotegut, et al.
Contemporary Clinical Trials|May 25, 2005
Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trialEvan R Myers, Susan G Silva, Gail Hafley, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|August 29, 2021
A Scoping Review of Unintended Pregnancy in Active Duty United States Military WomenCandy Wilson, Angela Kornegay Phillips, Stacey E Iobst, et al.
Obstetrics and Gynecology|January 1, 2008
Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID RegistryScott C Goodwin, James B Spies, Robert Worthington-Kirsch, et al.
Obstetrics and Gynecology|August 25, 2010
Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancerJason C Barnett, John P Judd, Jennifer M Wu, et al.
Circulation|March 15, 2006
Acute myocardial infarction in pregnancy: a United States population-based studyAndra H James, Margaret G Jamison, Mimi S Biswas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 14, 2013
Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancerAngeles Alvarez Secord, Jason Cory Barnett, Jonathan A Ledermann, et al.
The Journal of Urology|March 20, 2009
Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinenceJennifer M Wu, Nazema Y Siddiqui, Cindy L Amundsen, et al.
Pageof 21